Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Nature medicine | Feb 7, 2011

Hyperglycemia is associated with greater hematoma expansion and poor clinical outcomes after intracerebral hemorrhage. We show that cerebral hematoma expansion triggered by intracerebral infusion of autologous blood is greater in diabetic rats and mice compared to nondiabetic controls and that this augmented expansion is ameliorated by plasma kallikrein (PK) inhibition or deficiency. Intracerebral injection of purified PK augmented hematoma expansion in both diabetic and acutely hyperglycemic rats, whereas injection of bradykinin, plasmin or tissue plasminogen activator did not elicit such a response. This response, which occurs rapidly, was prevented by co-injection of the glycoprotein VI agonist convulxin and was mimicked by glycoprotein VI inhibition or deficiency, implicating an effect of PK on inhibiting platelet aggregation. We show that PK inhibits collagen-induced platelet aggregation by binding collagen, a response enhanced by elevated glucose concentrations. The effect of hyperglycemia on hematoma expansion and PK-mediated inhibition of platelet aggregation could be mimicked by infusing mannitol. These findings suggest that hyperglycemia augments cerebral hematoma expansion by PK-mediated osmotic-sensitive inhibition of hemostasis.

Pubmed ID: 21258336 RIS Download

Mesh terms: Animals | Blood-Brain Barrier | Brain | Cerebral Hemorrhage | Diabetes Mellitus, Experimental | Hematoma | Hyperglycemia | Injections, Intraventricular | Mice | Mice, Inbred C57BL | Plasma Kallikrein | Plasminogen | Platelet Aggregation | Rats | Rats, Sprague-Dawley

Research resources used in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: P01 HL087203
  • Agency: NHLBI NIH HHS, Id: HL090132
  • Agency: NEI NIH HHS, Id: EY19029
  • Agency: NEI NIH HHS, Id: R01 EY019029
  • Agency: NIDDK NIH HHS, Id: P30 DK036836
  • Agency: NHLBI NIH HHS, Id: R43 HL090132
  • Agency: NHLBI NIH HHS, Id: HL87203
  • Agency: NEI NIH HHS, Id: R01 EY019029-03
  • Agency: NHLBI NIH HHS, Id: HL07917
  • Agency: NHLBI NIH HHS, Id: T32 HL007917
  • Agency: NIDDK NIH HHS, Id: DK36836

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Joslin Diabetes Center Bioinformatics Core

Core that provides services for diabetes researchers in design, analysis, interpretation, publication, and data release of experiments involving all types of high-throughput omic data_ and their integration with each other, and with clinical and physiological data.

tool

View all literature mentions

Joslin Diabetes Center Flow Cytometry Core

Core that provides cell sorting and flow cytometry services. Specific services include cell analysis, large object sorting,magnetic cell enrichment, and automatic cell counting.

tool

View all literature mentions

Joslin Diabetes Center Advanced Microscopy Core

Core that provides services for performing specific morphological procedures, providing training and access to equipment, maintaining the specialized microscopes, and giving advice and interpretation.

tool

View all literature mentions

Joslin Diabetes Center Animal Physiology Core

Core that provides technically advanced physiological evaluation of metabolism in diabetes, obesity, and their associated complications in rodents for DRC investigators and outside users. It also provides training of investigators and trainees in several physiological procedures.

tool

View all literature mentions

Joslin Diabetes Center Advanced Genomics and Genetics Core

Core that provides services for genetic and genomic analysis, including DNA extraction from blood, access to DNA collections from the Core�s repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR.

tool

View all literature mentions

Joslin Diabetes Center Induced Pluripotent Stem Cell Core

Core that maintains a centralized facility for the generation and propagation of reprogrammed iPS cells for use in molecular and cellular pathologies underlying diabetes and its complications.

tool

View all literature mentions

Joslin Diabetes Center Enrichment Core

Six component core which facilitates the exchange of research information and discussions among investigators, fellows and students within the Joslin Diabetes Center, as well as between Joslin Staff and outside researchers with similar interests.

tool

View all literature mentions